C
OLMA icon

Covestor’s Olema Pharmaceuticals OLMA Stock Holding History

Covestor’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
19
+14
+280% +$188 ﹤0.01% 2738
2026
Q1 		$0 Sell
5
-11
-69% -$245 ﹤0.01% 2628
2025
Q4 		$0 Hold
16
– – ﹤0.01% 2604
2025
Q3 		$0 Hold
16
– – ﹤0.01% 2618
2025
Q2 		$0 Sell
16
-1
-6% -$4 ﹤0.01% 2591
2025
Q1 		$0 Buy
17
+10
+143% +$50 ﹤0.01% 2581
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2588
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2590
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2601
2024
Q1 		$0 Buy
+7
New +$90 ﹤0.01% 2589
2022
Q1 		– Sell
-15
Closed – – 2334
2021
Q4 		$0 Buy
+15
New +$311 ﹤0.01% 2241

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Covestor's OLMA Position: Q2 2026 in Review

Covestor increased its Olema Pharmaceuticals (OLMA) stake by 280% in Q2 2026, buying an estimated $188 and bringing the position to 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

Covestor first reported a position in OLMA in Q4 2021 and has held it in 11 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Covestor held 19 shares of Olema Pharmaceuticals worth $0 as of Q2 2026.
  • Covestor bought 14 Olema Pharmaceuticals shares in Q2 2026, an estimated $188.
  • Olema Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2738 holding.
  • Covestor first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.